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Modulation of Ion Channels: Minireview
A ªCurrentº View of AKAPs
to respond to distinct second messenger±mediated
signals.
Recently, reagents derived from the enzyme binding
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these proteins in functional coupling to a variety of ionPortland, Oregon 97201
channels. Many of these studies were made possible
by the development of an anchoring inhibitor peptide
derived from the RII binding site of an AKAP (Ht31),Deciphering the molecular organization of synapses and
which was shown to have a nanomolar binding affinitythe neuronal signaling events at the postsynaptic den-
for the kinase and thus would antagonize RII/AKAP bind-sity is shedding light on the complexity of ion channel
ing (Colledge and Scott, 1999). As this short peptidemodulation. Neuronal activity is mediated by changes
contained no intracellular targeting determinant, it wasin electrical activity, which depends on the movement
proposed to mediate a global uncoupling of PKA tar-of ions across the cell membrane through ion channels.
geting when introduced into cells at a sufficiently highThus, modulating the activity of ligand- and voltage-
concentration.gated ion channels allows the neuron to modify its re-
Glutamate Receptorssponse to a variety of stimuli. Defining the molecular
Rosenmund et al. (1994) were the first to investigate amechanisms that underlie ion channel regulation is a
functional role for anchored PKA in neurons. Perfusionformidable task for neurobiologists. One aspect of this
of the Ht31 anchoring inhibitor peptide into culturedcomplex process that has received considerable atten-
rat hippocampal neurons promoted a time-dependenttion recently is the modulation of channel activity by
rundown of AMPA/kainate responsive currents, whichprotein phosphorylation.
had been shown previously to require PKA phosphoryla-Many of the broad specificity kinases and phospha-
tion to maintain function (Rosenmund et al., 1994, andtases have been implicated in the regulation of a consid-
references therein). The PKA-specific inhibitor PKI medi-erable number of channels, and several ion channel
ated a similar rundown in current, while the Ht31 peptidephosphorylation sites have been identified that could
effect could be overcome with perfusion of excess PKApotentially have modulatory roles (Catterall, 1991; Levi-
catalytic subunit. Furthermore, a mutant Ht31 peptide,tan, 1999; Swope et al., 1999). However, elucidating the
unable to antagonize RII/AKAP interactions, had no ef-mechanisms by which these enzymes achieve specific-
fect on the current. These experiments provided evi-ity has been challenging. Certain kinases and phospha-
dence of a role for kinase anchoring in PKA-mediatedtases appear to be intimately associated with ion chan-
synaptic events; however, they did not specifically ad-nels (Reinhart and Levitan, 1995; Yu et al., 1997). In the
dress which anchoring protein performed this role atcase of protein kinase A (PKA) and the type-1 phospha-
synapses.tase (PP-1), such specificity may be achieved by com-
A more recent report from Greengard and colleaguespartmentalization of the enzymes with their substrates.
suggests that phosphatase targeting may be equallyThe focus of this minireview is to highlight advances on
important in the modulation of AMPA-type glutamatethe targeting and functional coupling of PKA, and more
receptors (Yan et al., 1999). In an elegant series of bio-recently PP-1, with ion channels through association
chemical and electrophysiological experiments, Yan etwith targeting subunits and anchoring proteins.
al. (1999) have demonstrated that the characteristicThe AKAP Model
time-dependent rundown of AMPA receptors in neostri-
Subcellular localization of PKA occurs through associa-
atal neurons is mediated by PP-1. AMPA currents were
tion with A-kinase anchoring proteins (AKAPs). AKAPs
maintained by inhibiting the phosphatase with either
are a functionally related family of proteins that are de- okadaic acid or the activated inhibitor protein DARPP-
fined by their ability to associate with the PKA holoen- 32. Evidence for a more sophisticated level of regulation
zyme (Rubin, 1994; Colledge and Scott, 1999). Each is suggested by data showing that the PP-1-targeting
anchoring protein contains at least two functional mo- protein spinophilin, which is enriched in dendritic spines,
tifs. The conserved PKA binding domain forms an am- may function to concentrate PP-1 close to the AMPA
phipathic helix, which slots into a hydrophobic pocket receptor. A peptide antagonist to the PP-1 binding site
formed by residues in the extreme N terminus of the of spinophilin was able to maintain channel activity, pre-
kinase's regulatory subunit dimer (RII). Secondly, each sumably by uncoupling targeted PP-1, while having no
AKAP contains a unique targeting domain that directs direct effect on the catalytic activity of the phosphatase.
the kinase/AKAP complex to a defined intracellular loca- It should be noted that this does not directly demon-
tion. An additional feature of many AKAPs is their ability strate that PP-1 is coupled to AMPA receptors via
to form multivalent signaling complexes by associating spinophilin in vivo. The PP-1 binding peptide, in a man-
with more than one enzyme (see Colledge and Scott, ner similar to the Ht31 peptide's disruption of anchored
1999, for references). Coordinate binding of specific PKA, would mediate a widespread disruption of PP-1
combinations of enzymes could allow such complexes from all targeting subunits. Nonetheless, these data sup-
port an interesting model for the dopaminergic modula-
tion of glutamate channels in neostriatal neurons. Acti-* To whom correspondence should be addressed (e-mail: scott@
ohsu.edu). vation of D1-type dopamine receptors promotes PKA
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modulation of channel currents. Elevation of cAMP re-
leases the anchored kinase to phosphorylate and upreg-
ulate channel activity. Since yotiao appears to be highly
specific for C1 exon±containing NR1 subunits of NMDA
receptors, it remains to be determined whether other
NMDA receptors engage different AKAPs to perform a
similar regulatory function. It is tempting to suggest that
the requirement for locally anchored active phospha-
tase, observed with both NMDA and AMPA receptor
subtypes (Westphal et al., 1999; Yan et al., 1999), may
represent a common regulatory mechanism to maintain
low-level activity for these channels in the absence of
second messenger±mediated stimuli.
Ca21 Channels
Voltage-dependent L-type Ca21 channels are potenti-
ated in response to sustained membrane depolarization
or by trains of high-frequency depolarizations that mimic
action potentials (Catterall, 1991). These ion channelsFigure 1. Signaling Enzymes and Anchoring Proteins at Glutamate
were among the first shown to be dependent on phos-Receptors
phorylation, and biochemical studies demonstrated thatSchematic diagram depicting targeting of signaling enzymes to
kinase activity copurified with the channel. PKA wasAMPA (A) and NMDA (B) glutamate receptors through anchoring
identified as the copurifying kinase and subsequentlyproteins. In each case, a single receptor subunit is shown, four of
which are proposed to assemble to form a functional channel. shown to be responsible for channel regulation through
phosphorylation of the pore-forming a1 channel subunit
(see Gray et al., 1997, for references).phosphorylation of DARPP-32 that, in its phosphory-
PKA phosphorylation is essential for the prepulse po-lated form, can directly inhibit the anchored PP-1. Fur-
tentiation and subsequent slow deactivation of skeletalthermore, AMPA channel activity is increased by direct
muscle L-type Ca21 channels. Since changes in the ac-PKA phosphorylation, which, when considered in light
tivity of these channels occurs rapidly on a millisecondof the data from Rosenmund et al. (1994), could implicate
timescale, it seemed surprising that PKA was capablea nearby pool of anchored kinase. However, the ques-
of regulating this response since, upon cAMP activation,tion of how PKA may be targeted to these channels
rapid phosphorylation of the channel would be ham-remains open (Figure 1A).
pered by diffusion limits on the catalytic subunit. An-More recently, it has been demonstrated that NMDA
choring of PKA in close proximity to the channel couldreceptor subtypes also maintain their own anchored
satisfy the need for rapid activation. In cultured myo-phosphatase/kinase signaling complex. Yotiao, a pro-
tubes, Catterall and colleagues demonstrated that an-
tein initially identified on the basis of its interaction with
choring inhibitor peptides prevented prepulse potentia-
the C1 exon of the NR1 subunit of NMDA receptors, has
tion of L-type channels, suggesting that anchored PKA
been shown to target both PP-1 and PKA to the channel
was indeed important for channel regulation (Johnson
(Figure 1B; Westphal et al., 1999). Yotiao binds the ki- et al., 1994). Similar results were obtained using heterol-
nase through a conventional PKA binding domain that ogously expressed skeletal muscle Ca21 channel sub-
is similar to other AKAPs, while a distinct region of the units in kidney cells (Johnson et al., 1997). The results
protein binds PP-1. Although yotiao is not the only AKAP of the latter study were notable in that PKA anchoring±
that simultaneously binds a kinase and a phosphatase dependent regulation was reconstituted without heterol-
(Colledge and Scott, 1999), it is the first demonstration of ogous coexpression of an AKAP with the channel sub-
an anchored signaling complex in which both enzymes units. This suggests that an AKAP in the nonmuscle cell
coordinately regulate the activity of the same substrate. was capable of coupling with the expressed channel,
Enzymological analysis suggests that yotiao tethers although it should be noted that the same AKAP could
PP-1 in an active state, favoring dephosphorylation un- be expressed in both cell types.
der resting conditions. Support for this model comes Cardiac L-type Ca21 channels are also regulated by
from electrophysiological analysis of NMDA receptor anchored PKA, although it has not been proven that
currents. Tonic PP-1 activity attenuated receptor activ- prepulse potentiation of these channels is AKAP depen-
ity, as direct inhibition of the enzyme with okadaic acid dent. A membrane-targeted AKAP, AKAP79, was shown
led to an increase in glutamate-evoked currents. How- to reconstitute PKA regulation of the channel when ex-
ever, the same outcome was observed when a peptide pressed with cardiac Ca21 channel subunits in HEK 293
derived from the phosphatase binding site of another cells (Gao et al., 1997). Since this anchoring protein
PP-1-targeting protein, the muscle glycogen regulatory is not expressed in cardiac tissue, it is possible that
subunit (Gm), was included in the patch pipette. Since AKAP79, through its association with the plasma mem-
Gm has no inhibitory effect on PP-1 catalytic activity, brane, simply maintains PKA close to the channel in a
this result parallels that observed with the spinophilin heterologous expression system.
peptide and the AMPA receptor (Yan et al., 1999). Both The possibility that AKAP79 is not coupled to L-type
studies demonstrate that not only is active PP-1 re- Ca21 channels in vivo was supported by the detection
quired, but that specific targeting of tonically active of a low±molecular weight RII binding protein, named
AKAP15, which copurified and coimmunoprecipitatedphosphatase may be an equally important event in the
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Potassium Channels
Several protein kinases, including PKA, have been
shown to regulate the activity of calcium-activated po-
tassium channels (KCa) when added exogenously (Levi-
tan, 1999). Wang and Kotlikoff (1996) identified PKA as
an endogenous kinase responsible for the ATP-depen-
dent augmentation of large conductance KCa channels
in equine tracheal myocytes. Furthermore, a require-
ment for PKA anchoring was demonstrated when the
Ht31 anchoring inhibitor peptide blocked ATP-depen-
dent modulation of the channel (Figure 2B).
Another class of PKA-modulated potassium channel,
the ROMK-like K1 secretory channel (first cloned from
a rat outer medulla kidney expression library), may also
be modulated by a pool of anchored kinase. Ali et al.
(1998) demonstrated that PKA-mediated activation of
ROMK1, by either forskolin or the cAMP analog 8-bromo-
Figure 2. Signaling Enzymes and Anchoring Proteins at Ca21 and cAMP, is dependent on coexpression of AKAP79 in Xen-
K1 Channels opus oocytes (Figure 2B). Once again, this illustrates
(A) Targeting of PKA to the L-type Ca21 channel through interaction that AKAP79 is able to promote phosphorylation of
with AKAP15/18. The schematic for the channel depicts the pore- membrane-bound PKA substrates in a heterologous ex-
forming a1 subunit, which is proposed to be the target for regulation pression system. However, a ROMK-coupled AKAP of
by PKA phosphorylation.
100±120 kDa was identified by Ali et al. (1998), sug-(B) Targeting of signaling enzymes to K1 channels. Single subunits
gesting that AKAP79 is unlikely to be the physiologicalfor the large-conductance Ca21-activated K1 channel (KCa) and the
partner of the channel. A more likely candidate mayROMK channel are shown. In each case, four such subunits assem-
ble to form a complete channel. be AKAP-KL, a family of alternatively spliced anchoring
proteins enriched in kidney and lung that have been
identified by Rubin and colleagues (Dong et al., 1998).
Certain AKAP-KL isoforms migrate in the 100±120 kDawith the Ca21 channel from rabbit skeletal muscle (Gray
range and, like ROMK, are targeted to the apical mem-et al., 1997). In parallel studies, a small 80-residue AKAP,
brane in kidney epithelia.named AKAP18, was cloned from a human brain cDNA
Conclusionsexpression library and shown to be targeted to the
Given the central importance of ion channels in neuronalplasma membrane through N-terminal lipid modifica-
excitability, it is not surprising that several layers oftion. Myristoylation of the N-terminal glycine residue and
regulation contribute to their tight control. While neuro-dual palmitoylation of cysteines at positions 4 and 5
transmitter binding or membrane depolarization are themediate AKAP18 targeting (Fraser et al., 1998). Subse-
primary stimuli for ligand-gated and voltage-gated ionquently, AKAP15 was cloned and found to be identical
channels, respectively, it is now clear that kinases andto AKAP18 (Gray et al., 1998a) (for the purposes of clar-
phosphatases play a prominent role in modulating theity, we will henceforth refer to this AKAP as AKAP15/18).
activity of these channels.Identification of AKAP15/18 mRNA in skeletal muscle,
In addition, it appears that this fine tuning of channelheart, brain, and pancreas is more consistent with the
activity is facilitated by the molecular organization ofexpression pattern of the L-type Ca21 channel. Further-
signaling enzymes with ion channels. This is where
more, detection of AKAP15/18 mRNA in kidney could
AKAPs and phosphatase targeting subunits play their
account for the reconstitution of cAMP-dependent skel-
part. AKAP15/18 and AKAP79 have been linked to sev-
etal muscle channel activity in kidney-derived cells eral types of ion channels, although neither has yet been
(Johnson et al., 1997). Since AKAP15/18 was capable of shown to bind directly to a specific channel subunit. As
reconstituting cAMP-dependent channel activity when both anchoring proteins are targeted to submembrane
coexpressed with cardiac channel subunits (Fraser et sites through protein±lipid interactions, they maintain
al., 1998), and a peptide derived from the RII binding anchored pools of PKA close to ion channels. This might
site of AKAP15/18 inhibited voltage-dependent potenti- explain why these anchoring proteins appear to be func-
ation of skeletal muscle channels (Gray et al., 1998a), it tionally interchangeable in heterologous expression
seems a more likely physiological partner for both skele- systems (Gao et al., 1997; Fraser et al., 1998).
tal and cardiac L-type Ca21 channels than AKAP79 (Fig- In contrast, yotiao binds directly to C1 exon±con-
ure 2A). It has not yet been shown that AKAP15/18 di- taining NR1 subunits of NMDA receptors (Figure 1B;
rectly interacts with the L-type Ca21 channel, so it Westphal et al., 1999). Potentially, this may allow for
remains possible that coimmunoprecipitation of the two greater precision in regulation, as the anchored pool
proteins involves an intermediate adaptor protein. It is of kinase and phosphatase are directed to a specific
worth noting that, more recently, AKAP15/18 has also substrate. Such a sophisticated level of molecular orga-
been shown to coimmunoprecipitate with sodium chan- nization may be particularly relevant for the precise con-
nels purified from rat brain (Tibbs et al., 1998). Since trol of synaptic transmission. Since NMDA receptors
these channels are inhibited by PKA phosphorylation, it have been shown to be clustered at the postsynaptic
is tempting to speculate that modulation of brain sodium density with other ion channels, physical association of
the yotiao signaling complex with C1 exon±containingchannels will also depend on PKA anchoring.
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receptors would enhance preferential modulation of
these channels. However, an equally important property
of yotiao may be to restrict access of PKA and PP-1 to
other potential glutamate receptor substrates clustered
nearby through interaction with PDZ domain±containing
proteins such as PSD-95, Homer, and GRIP. We antici-
pate that the role of AKAPs in the modulation of ion chan-
nels will be clarified as our understanding of the molecular
architecture supporting channel function improves.
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